![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/00 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61K 51/10 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 37/04 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
C07K 16/30 | (2006.01) | ||
G01N 33/574 | (2006.01) |
(11) | Number of the document | 3041507 |
(13) | Kind of document | T |
(96) | European patent application number | 14852746.8 |
Date of filing the European patent application | 2014-08-26 | |
(97) | Date of publication of the European application | 2016-07-13 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
(46) | Date of publication of the claims translation | 2021-08-25 |
(86) | Number | PCT/US2014/052631 |
Date | 2014-08-26 |
(87) | Number | WO 2015/053871 |
Date | 2015-04-16 |
(30) | Number | Date | Country code |
201361870137 P | 2013-08-26 | US |
(72) |
SAWADA, Ritsuko , US
SUN, Shu-Man , US
SCHOLZ, Wolfgang , US
|
(73) |
BioNTech Research and Development, Inc. ,
228 E 45th Street, St. 9e, New York, NY 10017,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Nukleorūgštys, koduojančios antikūnus prieš sialil-Lewis a |
NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A |
Payment date | Validity (years) | Amount | |
2025-07-23 | 12 | 289.00 EUR |
2026-08-26 |